BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2189909)

  • 21. [Treatment of bullous pemphigoid by plasma exchange and prednisolone].
    Guillaume JC; Roujeau JC; Touzet C; Revuz J; Touraine R
    Presse Med; 1985 May; 14(20):1139-42. PubMed ID: 3158980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Azathioprine hypersensitivity in bullous pemphigoid.
    Collison DW; Dahlberg PJ; Hogan JD
    J Am Acad Dermatol; 1990 Jul; 23(1):125-7. PubMed ID: 2195071
    [No Abstract]   [Full Text] [Related]  

  • 23. [Successful treatment of autoimmune bullous diseases with a combination therapy of ciclosporin and corticosteroid].
    Kato H; Murata S; Suzuki M; Yaoita H
    Nihon Hifuka Gakkai Zasshi; 1989 Jan; 99(1):53-7. PubMed ID: 2664289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prednisolone and chlorambucil treatment in idiopathic membranous nephropathy with deteriorating renal function.
    Mathieson PW; Turner AN; Maidment CG; Evans DJ; Rees AJ
    Lancet; 1988 Oct; 2(8616):869-72. PubMed ID: 2902317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long term plasma exchange therapy in bullous pemphigoid.
    Guillot B; Donadio D; Guilhou JJ; Meynadier J
    Acta Derm Venereol; 1986; 66(1):73-5. PubMed ID: 2424224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of a chlorambucil-prednisolone combination with an azathioprine-prednisolone combination for treatment of chronic enteropathy with concurrent protein-losing enteropathy in dogs: 27 cases (2007-2010).
    Dandrieux JR; Noble PJ; Scase TJ; Cripps PJ; German AJ
    J Am Vet Med Assoc; 2013 Jun; 242(12):1705-14. PubMed ID: 23725434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erythromycin therapy in bullous pemphigoid: possible anti-inflammatory effects.
    Fox BJ; Odom RB; Findlay RF
    J Am Acad Dermatol; 1982 Oct; 7(4):504-10. PubMed ID: 6754772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bullous pemphigoid in a dog: treatment with six-mercaptopurine.
    White SD; Rosser EJ; Ihrke PJ; Stannard AA
    J Am Vet Med Assoc; 1984 Sep; 185(6):683-6. PubMed ID: 6386774
    [No Abstract]   [Full Text] [Related]  

  • 29. Adjuvant high-dose intravenous gammaglobulin in the treatment of pemphigus and bullous pemphigoid: experience in six patients.
    Beckers RC; Brand A; Vermeer BJ; Boom BW
    Br J Dermatol; 1995 Aug; 133(2):289-93. PubMed ID: 7547400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunosuppressive therapy for autoimmune bullous diseases.
    Meurer M
    Clin Dermatol; 2012; 30(1):78-83. PubMed ID: 22137230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bullous pemphigoid controlled by tetracycline.
    Thornfeldt CR; Menkes AW
    J Am Acad Dermatol; 1987 Feb; 16(2 Pt 1):305-10. PubMed ID: 3546415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chlorambucil treatment of frequently relapsing nephrotic syndrome.
    Grupe WE; Makker SP; Ingelfinger JR
    N Engl J Med; 1976 Sep; 295(14):746-9. PubMed ID: 958261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An open, multicentre, randomized clinical study in patients with bullous pemphigoid comparing methylprednisolone and azathioprine with methylprednisolone and dapsone.
    Sticherling M; Franke A; Aberer E; Gläser R; Hertl M; Pfeiffer C; Rzany B; Schneider S; Shimanovich I; Werfel T; Wilczek A; Zillikens D; Schmidt E
    Br J Dermatol; 2017 Nov; 177(5):1299-1305. PubMed ID: 28494097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of oral and topical corticosteroids in patients with bullous pemphigoid.
    Joly P; Roujeau JC; Benichou J; Picard C; Dreno B; Delaporte E; Vaillant L; D'Incan M; Plantin P; Bedane C; Young P; Bernard P;
    N Engl J Med; 2002 Jan; 346(5):321-7. PubMed ID: 11821508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bullous pemphigoid refractory to recommended dosage of prednisolone in a dog.
    Turnwald GH; Ochoa R; Barta O
    J Am Vet Med Assoc; 1981 Sep; 179(6):587-91. PubMed ID: 7021508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute pancreatitis: a fatal complication of treatment of bullous pemphigoid with systemic corticosteroids.
    Keefe M; Munro F
    Dermatologica; 1989; 179(2):73-5. PubMed ID: 2676630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Observations of the immunopathology and therapy of canine pemphigus and pemphigoid.
    Scott DW; Manning TO; Smith CA; Lewis RM
    J Am Vet Med Assoc; 1982 Jan; 180(1):48-52. PubMed ID: 6799473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of glucocorticoid-induced osteoporosis in immunobullous diseases with alendronate: a randomized, double-blind, placebo-controlled study.
    Tee SI; Yosipovitch G; Chan YC; Chua SH; Koh ET; Chan YH; Tan SS; Tsou IY; Tan SH
    Arch Dermatol; 2012 Mar; 148(3):307-14. PubMed ID: 22105813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bullous dermatosis. Bullous pemphigoid.
    Vano-Galvan S; Carrillo R; Moreno C; Jaen P
    Neth J Med; 2009 May; 67(5):200-1. PubMed ID: 19581675
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of cyclosporin on bullous pemphigoid and pemphigus.
    Thivolet J; Barthelemy H; Rigot-Muller G; Bendelac A
    Lancet; 1985 Feb; 1(8424):334-5. PubMed ID: 2857378
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.